{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:35:23Z","timestamp":1792683323776,"version":"4.5.0"},"reference-count":14,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2026,1,13]]},"DOI":"10.1136\/ejhpharm-2025-004739","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:20:13Z","timestamp":1769797213000},"page":"ejhpharm-2025-004739","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Fully validated HPLC-UV detection method associated with colour variation control for evaluation of the stability of 5-fluorouracil chemotherapy polyolefin infusion bags at dose banding"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4571-7780","authenticated-orcid":false,"given":"Yves","family":"Guillaume","sequence":"first","affiliation":[{"name":"University of Franche-Comt\u00e9, Besan\u00e7on, Bourgogne-Franche-Comt\u00e9, France"},{"name":"P\u00f4le Pharmaceutique, CHRU de Besan\u00e7on, Besan\u00e7on, Bourgogne-Franche-Comt\u00e9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Andr\u00e9","sequence":"additional","affiliation":[{"name":"Franche-Comte University Faculty of Medical and Pharmaceutical Sciences, Besancon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydie","family":"Lethier","sequence":"additional","affiliation":[{"name":"Franche-Comte University Faculty of Medical and Pharmaceutical Sciences, Besancon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026013010200864000_ejhpharm-2025-004739v1.1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules13081551"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/0731-7085(95)01635-X"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.3","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1177\/10781552231152618","article-title":"Long-term stability of 5-fluorouracil at standardized rounded doses in sodium chloride infusion polyolefin bags, stored at room temperature","volume":"29","author":"Closset","year":"2023","journal-title":"J Oncol Pharm Pract"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.4","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12010046","article-title":"Effect of Formulation Factors and Oxygen Levels on the Stability of Aqueous Injectable Solution Containing Pemetrexed","volume":"12","author":"Won","year":"2020","journal-title":"Pharmaceutics"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.5","first-page":"331","article-title":"Application of instrumental colour measurement in development and quality control of drugs and pharmaceutical excipients","volume":"63","author":"Subert","year":"2008","journal-title":"Pharmazie"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpba.2014.06.015","article-title":"Hydrolytic pathway of 5-fluorouracil in aqueous solutions for clinical use","volume":"98","author":"Legay","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.7","first-page":"5","article-title":"Monography 2.2.2. Degree of coloration of liquids","volume":"10","year":"2021","journal-title":"European Pharmacopoeia"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.8","unstructured":"United States Pharmacopeia . USP Color: Instrumental measurement. USPNF 2021;44."},{"key":"2026013010200864000_ejhpharm-2025-004739v1.9","doi-asserted-by":"crossref","unstructured":"Choudhury AKR . Using instruments to quantify colour. Elsevier 2014;270\u2013317. doi:10.1533\/9780857099242.270","DOI":"10.1533\/9780857099242.270"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.10","unstructured":"Xu QA , Trissel LA . Stability Indicating HPLC Methods for Drug Analysis. 2nd edn. Houston: AphA publications, 2003."},{"key":"2026013010200864000_ejhpharm-2025-004739v1.11","first-page":"101","article-title":"Validation des proc\u00e9dures analytiques quantitatives, Harmonisation des d\u00e9marches","volume":"13","author":"Hubert","year":"2003","journal-title":"STP Pharma Pratiques"},{"key":"2026013010200864000_ejhpharm-2025-004739v1.12","unstructured":"Validation of analytical procedures: text and methodology, q2(r1), current step 4 version. 1996."},{"key":"2026013010200864000_ejhpharm-2025-004739v1.13","unstructured":"USP . USP validation of compendial procedures. USP NF 2021;44."},{"key":"2026013010200864000_ejhpharm-2025-004739v1.14","doi-asserted-by":"crossref","unstructured":"Andre C , Lethier L , Guillaume YC . Long term and simulated in-use stabilities of irinotecan chemotherapy polyolefin infusion bags in dose banding conditions. J Oncol Pharm Pract 2025;doi. doi:10.1177\/10781552251338763","DOI":"10.1177\/10781552251338763"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2025-004739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T18:20:15Z","timestamp":1769797215000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2025-004739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":14,"alternative-id":["10.1136\/ejhpharm-2025-004739"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2025-004739","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]}}}